Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
4626 - 4650 of 9039 Results
Title
Year
  • Year
  • 2019
  • 2026
  • 2017
  • 2018
  • 2018
  • 2021
  • 2024
  • 2016
  • 2015
  • 2017
  • 2014
  • 2020
  • 2018
  • 2022
  • 2016
  • 2018
  • 2016
  • 2009
  • 2021
  • 2011
  • 2022
  • 2017
  • 2019
  • 2020
  • 2013
  • Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)
    2019
    Summary Details
    RESTRICTED
    Title: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)
    Author(s): Diane Stephenson, Mussie Akalu, Robert Alexander, Bastiaan R. Bloem, Babak Boroojerdi, Daniele Bravi, David J. Burn, Jesse M. Cedarbaum, Daniela J. Conrado, E. Ray Dorsey, Maurizio Facheris, Tanya Fischer, Mark Frasier, Jill Gallagher, Mark Forrest Gordon, Ole Graff, Donald G. Grosset, Zulfiqar Haider Sheikh, David Hill, Carole Ho, Michele Hu, Renee Hynds, Karl Kieburtz, Rachael A. Lawson, Sreeraj Macha, Efthymios Manolis, Kenneth Marek, Dawn C. Matthews, Timothy Nicholas, Gerald D. Podskalny, Anke Post, Klaus Romero, David H. Russell, John Seibyl, Bob Stafford, Glenn T. Stebbins, Maria Tome, Charles S. Venuto, Caroline H. Williams‐Gray, Alison J. Yarnall, David T. Dexter
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 92
    Issue #: 15_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010
    Citation Count: 1
  • Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicity
    2026
    Summary Details
    OPEN
    Title: Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicity
    Author(s): Nafisa Komilova, Noemi Esteras, Alessandra Preziuso, Lauren Millichap, Aušra Domanska, Anastasia Ludwig, Natalia Kulesskaya, Henri J. Huttunen, Kira M. Holmström, Andrey Y. Abramov, Plamena R. Angelova
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Vol: 195
    Issue #:
    Start Page: 119034
    End Page: 119034
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopha.2026.119034
    Best OA location URL: https://doi.org/10.1016/j.biopha.2026.119034
    Citation Count: 0
  • Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesia
    2017
    Summary Details
    OPEN
    Title: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesia
    Author(s): Andreas Dammann Andersen, Morten Blaabjerg, Michael Binzer, Akram Kamal, Helle Thagesen, Troels W. Kjær, Egon Stenager, Jan Bert Gramsbergen
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Vol: 141
    Issue #: 4
    Start Page: 614
    End Page: 625
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.13997
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997
    Citation Count: 44
  • Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons
    2018
    Summary Details
    OPEN
    Title: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons
    Author(s): Sarah A. McClymont, Paul W. Hook, Alexandra I. Soto, Xylena Reed, William Law, Samuel J. Kerans, Eric L. Waite, Nicole Briceno, Joseph F. Thole, Michael G. Heckman, Nancy N. Diehl, Zbigniew K. Wszołek, Cedric Moore, Heng Zhu, Jennifer A. Akiyama, Diane E. Dickel, Axel Visel, L Pennacchio, Owen A. Ross, M Beer, Andrew S. McCallion
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Vol: 103
    Issue #: 6
    Start Page: 874
    End Page: 892
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018
    Best OA location URL: http://www.cell.com/article/S0002929718303707/pdf
    Citation Count: 70
  • Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms
    2018
    Summary Details
    RESTRICTED
    Title: Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms
    Author(s): Kyle T. Mitchell, Paul Larson, Philip A. Starr, Michael S. Okun, Robert E. Wharen, Ryan J. Uitti, Barton L. Guthrie, DeLea Peichel, Rajesh Pahwa, Harrison C. Walker, Kelly D. Foote, Frederick J. Marshall, Joseph Jankovic, Richard K. Simpson, Fenna T. Phibbs, Joseph S. Neimat, R. Malcolm Stewart, Khashayar Dashtipour, Jill L. Ostrem
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 60
    Issue #:
    Start Page: 126
    End Page: 132
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.004
    Citation Count: 55
  • Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease
    2021
    Summary Details
    OPEN
    Title: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease
    Author(s): Yanyan Peng, Benjamin Liou, Yi Lin, Venette Fannin, Wujuan Zhang, Ricardo A. Feldman, Kenneth D.R. Setchell, Gregory A. Grabowski, Ying Sun
    Journal Name: Cells
    Publisher: MDPI AG
    Vol: 10
    Issue #: 9
    Start Page: 2286
    End Page: 2286
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells10092286
    Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2286/pdf?version=1630925823
    Citation Count: 21
  • Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case series
    2024
    Summary Details
    RESTRICTED
    Title: Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case series
    Author(s): Gemma Moya‐Galé, George Pagano, Stephen J. Walsh
    Journal Name: International Journal of Speech-Language Pathology
    Publisher: Informa UK Limited
    Vol: 27
    Issue #: 2
    Start Page: 205
    End Page: 220
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/17549507.2024.2330538
    Citation Count: 7
  • Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease
    2016
    Summary Details
    OPEN
    Title: Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease
    Author(s): Andrew Ridder, Martijn L.T.M. Müller, Vikas Kotagal, Kirk A. Frey, Roger L. Albin, Nicolaas I. Bohnen
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 34
    Issue #:
    Start Page: 15
    End Page: 19
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.10.006
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5222688
    Citation Count: 40
  • Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice
    2015
    Summary Details
    RESTRICTED
    Title: Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice
    Author(s): K. Zhang, C. Chammas, Jean‐Jacques Soghomonian
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Vol: 303
    Issue #:
    Start Page: 586
    End Page: 594
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.032
    Citation Count: 18
  • Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease
    2017
    Summary Details
    RESTRICTED
    Title: Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease
    Author(s): John N. Caviness, Thomas G. Beach, Joseph G. Hentz, Holly A. Shill, Erika Driver‐Dunckley, Charles H. Adler
    Journal Name: Clinical EEG and Neuroscience
    Publisher: SAGE Publications
    Vol: 49
    Issue #: 5
    Start Page: 321
    End Page: 327
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/1550059417696179
    Citation Count: 11
  • Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits
    2014
    Summary Details
    OPEN
    Title: Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits
    Author(s): Shababa T. Masoud, Laura M. Vecchio, Y. Bergeron, Muhammad M. Hossain, Long Nguyen, Marie Kristel Bermejo, Brian M. Kile, T.D. Sotnikova, William B. Siesser, Raul R. Gainetdinov, R. Mark Wightman, Marc G. Caron, Jason R. Richardson, Gary W. Miller, Amy J. Ramsey, Michel Cyr, Ali Salahpour
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Vol: 74
    Issue #:
    Start Page: 66
    End Page: 75
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.016
    Best OA location URL: http://doi.org/10.1016/j.nbd.2014.10.016
    Citation Count: 158
  • Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates
    2020
    Summary Details
    OPEN
    Title: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates
    Author(s): Matthew C. Deen, Cameron Proceviat, Xiaoyang Shan, Liang Wu, David L. Shen, G.J. Davies, David J. Vocadlo
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Vol: 15
    Issue #: 4
    Start Page: 824
    End Page: 829
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.9b01044
    Citation Count: 12
  • Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liability
    2018
    Summary Details
    OPEN
    Title: Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liability
    Author(s): Darren W. Engers, Sean R. Bollinger, Julie L. Engers, Joseph D. Panarese, Megan M. Breiner, Alison R. Gregro, Anna L. Blobaum, Joanne J. Bronson, Yong‐Jin Wu, John E. Macor, Alice L. Rodriguez, Rocio Zamorano, P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Corey R. Hopkins
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Vol: 28
    Issue #: 15
    Start Page: 2641
    End Page: 2646
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2018.06.034
    Best OA location URL: https://doi.org/10.7270/q2dr2z5h
    Citation Count: 14
  • The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
    2022
    Summary Details
    OPEN
    Title: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
    Author(s): Nicole K. Polinski, Terina N. Martinez, Sylvie Ramboz, Michael Sasner, Mark T. Herberth, Robert Switzer, S. Omar Ahmad, Lee J. Pelligrino, Sean W. Clark, Jacob Marcus, Sean M. Smith, Kuldip D. Dave, Mark Frasier
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Vol: 15
    Issue #: 6
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049192
    Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdf
    Citation Count: 18
  • A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease
    2016
    Summary Details
    RESTRICTED
    Title: A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease
    Author(s): Nicholas T. Seyfried, Eric B. Dammer, Vivek Swarup, Divya Nandakumar, Duc M. Duong, Luming Yin, Qiudong Deng, Tram Thi Hong Nguyen, Chadwick M. Hales, Thomas S. Wingo, Jonathan D. Glass, Marla Gearing, Madhav Thambisetty, Juan C. Troncoso, Daniel H. Geschwind, James J. Lah, Allan I. Levey
    Journal Name: Cell Systems
    Publisher: Elsevier BV
    Vol: 4
    Issue #: 1
    Start Page: 60
    End Page: 72.e4
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cels.2016.11.006
    Best OA location URL: http://doi.org/10.1016/j.cels.2016.11.006
    Citation Count: 532
  • Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
    2018
    Summary Details
    OPEN
    Title: Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
    Author(s): Waijiao Cai, Danielle Feng, Michael A. Schwarzschild, Pamela J. McLean, Xiqun Chen
    Journal Name: EBioMedicine
    Publisher: Elsevier BV
    Vol: 29
    Issue #:
    Start Page: 13
    End Page: 22
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2018.01.035
    Best OA location URL: http://www.thelancet.com/article/S2352396418300392/pdf
    Citation Count: 31
  • Identification of small molecules that bind to the mitochondrial protein mitoNEET
    2016
    Summary Details
    OPEN
    Title: Identification of small molecules that bind to the mitochondrial protein mitoNEET
    Author(s): Werner J. Geldenhuys, Heather M. Yonutas, Daniel L. Morris, Patrick G. Sullivan, Altaf S. Darvesh, Thomas C. Leeper
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Vol: 26
    Issue #: 21
    Start Page: 5350
    End Page: 5353
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.09.009
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5482219
    Citation Count: 40
  • Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
    2009
    Summary Details
    OPEN
    Title: Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
    Author(s): Chadwick W. Christine, Philip A. Starr, Paul Larson, Jamie L. Eberling, William J. Jagust, Richard A. Hawkins, Henry F. VanBrocklin, Joan Wright, Krystof S. Bankiewicz, Michael J. Aminoff
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 73
    Issue #: 20
    Start Page: 1662
    End Page: 1669
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356
    Best OA location URL: https://n.neurology.org/content/neurology/73/20/1662.full.pdf
    Citation Count: 429
  • Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease
    2021
    Summary Details
    OPEN
    Title: Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease
    Author(s): Melina Bordone, Ana Damianich, Alejandra Bernardi, Tomas Eidelman, Sara Sanz‐Blasco, Oscar S. Gershanik, María Elena Avale, Juan E. Ferrario
    Journal Name: eneuro
    Publisher: Society for Neuroscience
    Vol: 8
    Issue #: 4
    Start Page: ENEURO.0559
    End Page: 20.2021
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/eneuro.0559-20.2021
    Best OA location URL: https://www.eneuro.org/content/eneuro/8/4/ENEURO.0559-20.2021.full.pdf
    Citation Count: 14
  • Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats
    2011
    Summary Details
    RESTRICTED
    Title: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats
    Author(s): Svenja E. Sander, Carol A. Lemm, Naomi F. Lange, Melanie Hamann, A. Richter
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Vol: 62
    Issue #: 2
    Start Page: 1052
    End Page: 1061
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016
    Citation Count: 24
  • Putting participants and study partners FIRST when clinical trials end early
    2022
    Summary Details
    OPEN
    Title: Putting participants and study partners FIRST when clinical trials end early
    Author(s): Emily A. Largent, Sarah Walter, Nancy M. Childs, Penny A. Dacks, Shana Dodge, Hana Florian, Jonathan Jackson, Jorge J. Llibre Guerra, Erin Iturriaga, David S. Miller, Monica Moreno, Rachel L. Nosheny, Thomas O. Obisesan, Elena Portacolone, Bernadette Siddiqi, Nina Silverberg, Rueben C. Warren, Kathleen A. Welsh‐Bohmer, Rebecca M. Edelmayer, the Participant FIRST Work Group
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Vol: 18
    Issue #: 12
    Start Page: 2736
    End Page: 2746
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12732
    Best OA location URL: https://doi.org/10.1002/alz.12732
    Citation Count: 10
  • Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)
    2017
    Summary Details
    RESTRICTED
    Title: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)
    Author(s): Ganqiang Liu, Brendon Boot, Joseph J. Locascio, Zhixiang Liao, Daly Franco, Karen Duong, Kara Page, Iris E. Jansen, Tom Yi, Ana Trisini‐Lipsanopoulos, Xianjun Dong, Samantha J. Hutten, Sophie Winder‐Rhodes, Sami S. Amr, Caroline M. Tanner, Anthony E. Lang, Mike A. Nalls, Shirley Eberly, HBS, CamPaIGN, PICNICS, PROPARK, PSG, DIGPD, Lewis Sudarsky, Alexis Elbaz, Alexis Brice, Bernard Ravina, Ira Shoulson, Jacobus van Hilten, Florence Cormier‐Dequaire, Jean‐Christophe Corvol, Roger A. Barker, Peter Heutink, Johan Marinus, Caroline H. Williams‐Gray, Clemens R. Scherzer
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 88
    Issue #: 16_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002
    Citation Count: 0
  • Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)
    2019
    Summary Details
    RESTRICTED
    Title: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)
    Author(s): Christopher G. Tarolli, Grace A. Zimmerman, Steven Goldenthal, Blake Feldman, Sarah Berk, Bernadette Siddiqi, Catherine Kopil, Sohini Chowdhury, Kevin Biglan, E. Ray Dorsey, Jamie Adams
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 92
    Issue #: 15_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006
    Citation Count: 0
  • Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)
    2020
    Summary Details
    RESTRICTED
    Title: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)
    Author(s): Christopher S. Coffey, Michael C. Brumm, Andrew Siderowf, Tanya Simuni, Douglas Galasko, Brit Mollenhauer, Lana M. Chahine, Vanessa Arnedo, Mark Frasier, Caroline M. Tanner, Kathleen L. Poston, Daniel Weintraub, Samantha J. Hutten, Karl Kieburtz, Kenneth Marek, Nichole Daegle
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 94
    Issue #: 15_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402
    Citation Count: 0
  • The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)
    2013
    Summary Details
    RESTRICTED
    Title: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)
    Author(s): Mark Forrest Gordon, Thomas A. Comery, Igor D. Grachev, Donald G. Grosset, Chris Harbron, Mikko Kuoppamäki, Ken A. Lindstedt, Kenneth Marek, Patricia E. Cole, Dawn C. Matthews, Klaus Romero, Christopher S. Coffey, David Russell, John Seibyl, Todd Sherer, Yafit Stark, Rathan M. Subramaniam, Diane Stephenson
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 80
    Issue #: 7_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.